4-(3-Ethyl-2,4,4-trimethylcyclohex-2-enylidenemethyl)benzamide

ID: ALA3262378

PubChem CID: 90676375

Max Phase: Preclinical

Molecular Formula: C19H25NO

Molecular Weight: 283.42

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCC1=C(C)/C(=C/c2ccc(C(N)=O)cc2)CCC1(C)C

Standard InChI:  InChI=1S/C19H25NO/c1-5-17-13(2)16(10-11-19(17,3)4)12-14-6-8-15(9-7-14)18(20)21/h6-9,12H,5,10-11H2,1-4H3,(H2,20,21)/b16-12+

Standard InChI Key:  WAIVFZDQYZVFJB-FOWTUZBSSA-N

Molfile:  

     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
   25.9946   -3.0063    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.5860   -3.7154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7688   -3.7154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3602   -4.4245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5430   -4.4245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1344   -3.7154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5430   -3.0063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3602   -3.0063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9946   -4.4245    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.3131   -3.7154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9045   -3.0063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0873   -3.0063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6787   -2.3013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0873   -1.5922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9045   -1.5922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3131   -2.3013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2322   -0.7897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3201   -1.3132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6787   -3.7154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8616   -2.3013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4530   -1.5922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  3  8  2  0
  2  9  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 11 16  1  0
 14 17  1  0
 14 18  1  0
 12 19  1  0
 20 21  1  0
 13 20  1  0
 10 11  2  0
  6 10  1  0
  1  2  1  0
M  END

Associated Targets(Human)

TT (117 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 283.42Molecular Weight (Monoisotopic): 283.1936AlogP: 4.72#Rotatable Bonds: 3
Polar Surface Area: 43.09Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.22CX LogD: 4.22
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.86Np Likeness Score: 0.28

References

1. Zatelli MC, Gagliano T, Pelà M, Bianco S, Bertolasi V, Tagliati F, Guerrini R, degli Uberti E, Salvadori S, Trapella C..  (2014)  N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis.,  57  (11): [PMID:24761782] [10.1021/jm5000535]

Source